Causes of early death in multiple myeloma patients who are ineligible for high‐dose therapy with hematopoietic stem cell support: A study based on the nationwide Danish Myeloma Database
Open Access
- 5 January 2015
- journal article
- other
- Published by Wiley in American Journal of Hematology
- Vol. 90 (4), E73-E74
- https://doi.org/10.1002/ajh.23932
Abstract
No abstract availableKeywords
Funding Information
- Danish Cancer Society
This publication has 5 references indexed in Scilit:
- Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based studyThe Lancet Oncology, 2014
- Multiple myeloma in octogenarians: Clinical features and outcome in the novel agent eraEuropean Journal of Haematology, 2012
- High early mortality rate in elderly patients with multiple myeloma receiving a vincristine–doxorubicin–dexamethasone regimenAmerican Journal of Hematology, 2010
- Early Mortality After Diagnosis of Multiple Myeloma: Analysis of Patients Entered Onto the United Kingdom Medical Research Council Trials Between 1980 and 2002—Medical Research Council Adult Leukaemia Working PartyJournal of Clinical Oncology, 2005
- Multiple myeloma in elderly patients: presenting features and outcomeEuropean Journal of Haematology, 2001